Follow
Arthur M. Krieg
Arthur M. Krieg
University of Massachusetts Chan School of Medicine RNA Therapeutics Institute
Verified email at umassmed.edu
Title
Cited by
Cited by
Year
CpG motifs in bacterial DNA trigger direct B-cell activation
AM Krieg, AK Yi, S Matson, TJ Waldschmidt, GA Bishop, R Teasdale, ...
Nature 374 (6522), 546-549, 1995
48151995
CPG MOTIFS IN BACTERIAL DNA AND THEIR IMMUNE EFFECTS
AM Krieg
Annual review of immunology 20 (1), 709-760, 2002
34232002
Therapeutic potential of Toll-like receptor 9 activation
AM Krieg
Nature reviews Drug discovery 5 (6), 471-484, 2006
24042006
CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma.
DM Klinman, AK Yi, SL Beaucage, J Conover, AM Krieg
Proceedings of the national academy of sciences 93 (7), 2879-2883, 1996
20261996
Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848
M Jurk, F Heil, J Vollmer, C Schetter, AM Krieg, H Wagner, G Lipford, ...
Nature immunology 3 (6), 499-499, 2002
13682002
CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity
RS Chu, OS Targoni, AM Krieg, PV Lehmann, CV Harding
The Journal of experimental medicine 186 (10), 1623-1631, 1997
13561997
Identification of CpG oligonucleotide sequences with high induction of IFN‐α/β in plasmacytoid dendritic cells
A Krug, S Rothenfusser, V Hornung, B Jahrsdörfer, S Blackwell, ZK Ballas, ...
European journal of immunology 31 (7), 2154-2163, 2001
12022001
Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.
ZK Ballas, WL Rasmussen, AM Krieg
Journal of immunology (Baltimore, Md.: 1950) 157 (5), 1840-1845, 1996
10871996
Toll‐like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL‐12
A Krug, A Towarowski, S Britsch, S Rothenfusser, V Hornung, R Bals, ...
European journal of immunology 31 (10), 3026-3037, 2001
10762001
CpG DNA is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen
HL Davis, R Weeranta, TJ Waldschmidt, L Tygrett, J Schorr, AM Krieg
The Journal of Immunology 160 (2), 870-876, 1998
9991998
CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells
G Hartmann, GJ Weiner, AM Krieg
Proceedings of the National Academy of Sciences 96 (16), 9305-9310, 1999
9061999
Mechanism and function of a newly identified CpG DNA motif in human primary B cells
G Hartmann, AM Krieg
The Journal of Immunology 164 (2), 944-953, 2000
8962000
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
G Hartmann, RD Weeratna, ZK Ballas, P Payette, S Blackwell, I Suparto, ...
The Journal of Immunology 164 (3), 1617-1624, 2000
8362000
Immunostimulatory nucleic acid molecules
AM Krieg, J Kline, D Klinman, AD Steinberg
US Patent 6,207,646, 2001
825*2001
Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25+ regulatory T cells
EA Moseman, X Liang, AJ Dawson, A Panoskaltsis-Mortari, AM Krieg, ...
The Journal of Immunology 173 (7), 4433-4442, 2004
8122004
Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities
J Vollmer, R Weeratna, P Payette, M Jurk, C Schetter, M Laucht, T Wader, ...
European journal of immunology 34 (1), 251-262, 2004
7762004
Rapid and strong human CD8+ T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909
DE Speiser, D Liénard, N Rufer, V Rubio-Godoy, D Rimoldi, F Lejeune, ...
The Journal of clinical investigation 115 (3), 739-746, 2005
7722005
Cutting edge: modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma
JN Kline, TJ Waldschmidt, TR Businga, JE Lemish, JV Weinstock, ...
The Journal of Immunology 160 (6), 2555-2559, 1998
7711998
Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization
GJ Weiner, HM Liu, JE Wooldridge, CE Dahle, AM Krieg
Proceedings of the National Academy of Sciences 94 (20), 10833-10837, 1997
7341997
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
J Vollmer, AM Krieg
Advanced drug delivery reviews 61 (3), 195-204, 2009
6982009
The system can't perform the operation now. Try again later.
Articles 1–20